The Bruton's tyrosine kinase (BTK) inhibitor PCI-32765 (P) in treatment-naive (TN) chronic lymphocytic leukemia (CLL) patients (pts): Interim results of a phase Ib/II study.
暂无分享，去创建一个
J. Byrd | I. Flinn | N. Heerema | A. Johnson | S. O'brien | K. Blum | J. Burger | S. Coutre | R. Furman | J. Sharman | D. James | E. Hedrick | B. Grant | Tasheda Navarro